Core Insights - The China International Welfare Expo has reached its 18th year, marking a significant milestone in the development of the welfare industry in China [1] - The expo has evolved from showcasing basic assistive devices to featuring advanced technologies such as flexible exoskeleton robots and brain-machine interface rehabilitation systems [3] - The event has transformed into a platform that not only displays products but also integrates academic discussions, enhancing the visibility of assistive technology and promoting inclusive development [2][3] Industry Development - The first expo in 2007 was a modest beginning, focusing on basic assistive devices and primarily featuring domestic companies [1] - By 2008, the expo gained national attention, attracting over 100,000 visitors and promoting the concept of "technology for disability assistance" [2] - The international participation increased significantly by 2011, with 17 countries represented, indicating a new phase of international cooperation in the assistive device sector [2] Technological Advancements - The 2023 expo showcased cutting-edge products, highlighting the transition to an era of intelligent assistive technologies [3] - The event featured a special exhibition for the centenary of Rehabilitation International, emphasizing global collaboration and innovation in the field [3] Social Impact - The expo has become a key indicator of social progress in China, reflecting the shift from merely providing assistance to empowering individuals with disabilities [3][4] - The growth of the expo, from over 100 exhibitors to more than 400 leading brands, demonstrates a commitment to improving the quality of assistive devices and fostering an inclusive environment [3]

Core Insights - Brain-computer interface (BCI) technology enables direct communication between the brain and external devices, revolutionizing human-machine interaction and integrating advanced technologies such as neuroscience, AI, and new materials [2][4] - The global BCI industry is projected to reach $7.63 billion by 2029, indicating significant growth potential [4] - China and the United States are leading in BCI development, with a notable number of companies and products entering clinical stages [6][7] Industry Overview - The BCI industry is characterized by a competitive landscape with active companies in over 40 countries, primarily in the US and China, where the number of companies exceeds 100 [7] - As of early 2024, China holds 55.62% of the global patent technology in BCI, leading all countries [6] - The industry is still in its early stages, with many startups emerging and a significant increase in patent applications and funding events [55] Key Companies - **Qiangnao Technology**: Founded in 2018, it specializes in non-invasive BCI technology and has over 200 core patents, with a goal to help 1 million disabled individuals regain mobility [10][12] - **Brain Tiger Technology**: Established in 2021, it focuses on flexible invasive BCI technology and has made significant breakthroughs in core technologies [13][15] - **Brain Land Technology**: Founded in 2018, it integrates BCI technology with medical big data and AI, holding 147 patents as of April 2025 [20][21] - **Borecon**: Founded in 2021, it has developed high-performance BCI systems and has over 100 patents [24][25] - **Weiling Medical**: Established in 2019, it is focused on BCI technology and has initiated clinical research for implantable BCI systems [28] - **Roulint Technology**: Founded in 2020, it specializes in non-invasive BCI technology for consumer electronics and medical applications, holding 161 patents [33] - **Aipeng Medical**: Established in 2001, it has invested in BCI technology and developed several non-invasive BCI products [36][37] - **Kedou BCI**: Founded in 2016, it focuses on invasive BCI technology and has developed various microelectrodes and related devices [40][41] - **Sanbo Neuroscience**: Established in 2003, it has over 50 patents and is involved in clinical applications of BCI technology for neurological disorders [43] - **Chengyitong**: Founded in 2011, it has developed several non-invasive BCI prototypes and holds 303 patents, covering key areas of BCI technology [46] Technological Insights - BCI technology is categorized into invasive, semi-invasive, and non-invasive types, with a focus on improving accuracy, feedback speed, and safety [50][52] - The majority of BCI product development is currently centered on non-invasive devices due to their higher safety and market acceptance [53] - As of 2024, there are 222 registered medical devices related to BCI in China, with 194 classified as Class II medical devices [53]

报名：首届全球眼科大会 | 议程更新 报名：首届全球骨科大会 | 议程更新 报名：首届全球心血管大会 | 奖项申报 合作伙伴征集：2025全球手术机器人大会 据悉，2025年3月31日，湖北率先为脑机接口医疗服务定价，明确3个项目收费标准，为未来技术落地服务患者打下基础。 | 项目名称 | 价格(元/次) | | --- | --- | | 侵入式脑机接口 置入费 | 6552 | | 侵入式脑机接口 取出费 | 3139 | | 非侵入式脑机接口 适配費 | ે રેણ | # 意义分析 2025年3月12日，国家医保局发布 《神经系统类医疗服务价格项目立项指南》 ，其中专门为脑机接口新技术单独立项，设立了侵入式脑机接口置入费、取出费，非侵入式脑机接口适配费等价格项目。这意味着，一旦脑机接口技术成 熟，快速进入临床应用的收费路径已经铺好。 湖北省医保局于2025年3月31日发布全国首个脑机接口医疗服务价格，这一举措具有多方面的重要意义。 对医疗行业的意义： 此前脑机接口技术因收费模糊难以大规模临床应用，定价之后 3月中旬，国家医保局发布《神经系统类医疗服务价格项目立项指南》，其中专门为脑机接口新技术价格单独 ...

Investment Rating - The investment rating for the pharmaceutical and biotechnology industry is "Positive" (maintained) [1] Core Insights - The brain-computer interface (BCI) technology is experiencing rapid development and has promising commercial prospects, with a focus on diverse technical paths and applications in the medical field [5][6][32] - The BCI technology is categorized into invasive, semi-invasive, and non-invasive types, each with its own advantages in signal quality, safety, and operational difficulty [18][20] - The core technological barriers of BCI are concentrated in the upstream of the industry chain, including hardware (electrodes, chips), surgical procedures, and signal processing [25][28] Summary by Sections 1. BCI Development and Applications - BCI is a multidisciplinary technology that integrates neuroscience, computer science, and engineering to facilitate communication between the brain and external devices [15] - The medical application of BCI is predominant, accounting for 56% of the market in 2023, with potential in diagnosing and treating cognitive disorders, mental illnesses, and motor disabilities [33][36] 2. BCI Policy and Pricing - The National Healthcare Security Administration has established a pricing standard for BCI services, addressing the slow commercialization of BCI technology and creating a pricing framework that covers the entire service chain [40][42] 3. BCI Companies and Market Trends - Non-invasive BCI products are leading in commercialization, while invasive and semi-invasive products are still in clinical research stages [43] - Key companies in the BCI space include NeuroPace, BrainGate, Neuralink, and Paradromics, each focusing on various applications such as epilepsy treatment and motor function recovery [43]